GFPC
BIO icon

Global Financial Private Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Global Financial Private Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.29M Buy
2,864
+2,724
+1,946% +$1.2M 0.08% 188
2020
Q1 		$49K Buy
+140
New +$51.5K ﹤0.01% 269

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Global Financial Private Capital's BIO Position: Q2 2020 in Review

Global Financial Private Capital increased its Bio-Rad Laboratories Class A (BIO) stake by 1,946% in Q2 2020, buying an estimated $1.2M and bringing the position to 2,864 shares worth $1.29M. The position accounts for 0.08% of the portfolio, ranked #188.

Global Financial Private Capital first reported a position in BIO in Q1 2020 and has held it in 2 quarters since. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Global Financial Private Capital held 2,864 shares of Bio-Rad Laboratories Class A worth $1.29M as of Q2 2020.
  • Global Financial Private Capital bought 2,724 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $1.2M.
  • Bio-Rad Laboratories Class A made up 0.08% of Global Financial Private Capital's portfolio in Q2 2020, its #188 holding.
  • Global Financial Private Capital first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and has held it in 2 quarters since.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.